Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2 pathway

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 494-499

  Lu, Xiumin ^a,b   Su, Nan ^a   Yang, Jing ^a   Huang, Wei ^b   Li, Can ^a   Zhao, Ling ^a   He, Qifen ^a   Du, Xiaolan ^a   Shen, Yue ^a   Chen, Bo ^a   Chen, Lin ^a  

^a Burns and Combined Injury   (China)

^b CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Bone remodeling; FGFR1; MAPK; Osteoclast

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ACID PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; ISOENZYMES; MICE; MICE, MUTANT STRAINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; OSTEOCLASTS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;

MUS;

EID: 70450245264     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.123     Document Type: Article

References (40)

1. Chen L., and Deng C.X. Roles of FGF signaling in skeletal development and human genetic diseases. Front. Biosci. 10 (2005) 1961-1976
2. Ornitz D.M. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 16 (2005) 205-213
3. Ornitz D.M., and Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16 (2002) 1446-1465
4. Muenke M., and Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11 (1995) 308-313
5. Marie P.J., Coffin J.D., and Hurley M.M. FGF and FGFR signaling in chondrodysplasias and craniosynostosis. J. Cell. Biochem. 96 (2005) 888-896
6. Su N., Du X., and Chen L. FGF signaling: its role in bone development and human skeleton diseases. Front. Biosci. 13 (2008) 2842-2865
7. Wilkie A.O., Patey S.J., Kan S.H., Van den Ouweland A.M., and Hamel B.C. FGFs, their receptors, and human limb malformations: clinical and molecular correlations. Am. J. Med. Genet. 112 (2002) 266-278
8. Rousseau F., Bonaventure J., Legeai-Mallet L., Pelet A., Rozet J.M., Maroteaux P., Le Merrer M., and Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371 (1994) 252-254
9. Shiang R., Thompson L.M., Zhu Y.Z., Church D.M., Fielder T.J., Bocian M., Winokur S.T., and Wasmuth J.J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78 (1994) 335-342
10. Wilkie A.O., Slaney S.F., Oldridge M., Poole M.D., Ashworth G.J., Hockley A.D., Hayward R.D., David D.J., Pulleyn L.J., Rutland P., et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9 (1995) 165-172
11. Jabs E.W., Li X., Scott A.F., Meyers G., Chen W., Eccles M., Mao J.I., Charnas L.R., Jackson C.E., and Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat. Genet. 8 (1994) 275-279
12. Meyers G.A., Orlow S.J., Munro I.R., Przylepa K.A., and Jabs E.W. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat. Genet. 11 (1995) 462-464
13. Wilkie A.O., and Morriss-Kay G.M. Genetics of craniofacial development and malformation. Nat. Rev. Genet. 2 (2001) 458-468
14. Jacob A.L., Smith C., Partanen J., and Ornitz D.M. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev. Biol. (2006) 315-328
15. Muenke M., Schell U., Hehr A., Robin N.H., Losken H.W., Schinzel A., Pulleyn L.J., Rutland P., Reardon W., Malcolm S., et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8 (1994) 269-274
16. White K.E., Cabral J.M., Davis S.I., Fishburn T., Evans W.E., Ichikawa S., Fields J., Yu X., Shaw N.J., McLellan N.J., McKeown C., Fitzpatrick D., Yu K., Ornitz D.M., and Econs M.J. Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am. J. Hum. Genet. 76 (2005) 361-367
17. Yamaguchi T.P., Harpal K., Henkemeyer M., and Rossant J. Fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev. 8 (1994) 3032-3044
18. Hajihosseini M.K., Lalioti M.D., Arthaud S., Burgar H.R., Brown J.M., Twigg S.R., Wilkie A.O., and Heath J.K. Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131 (2004) 325-335
19. Zhou Y.X., Xu X., Chen L., Li C., Brodie S.G., and Deng C.X. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum. Mol. Genet. 9 (2000) 2001-2008
20. Karsenty G. Transcriptional control of skeletogenesis. Annu. Rev. Genomics Hum. Genet. 9 (2008) 183-196
21. Boyce B.F., and Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473 (2008) 139-146
22. Asagiri M., and Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 40 (2007) 251-264
23. Hofbauer L.C. Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. Eur. J. Endocrinol. 141 (1999) 195-210
24. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., McCabe S., Elliott R., Scully S., Van G., Kaufman S., Juan S.C., Sun Y., Tarpley J., Martin L., Christensen K., McCabe J., Kostenuik P., Hsu H., Fletcher F., Dunstan C.R., Lacey D.L., and Boyle W.J. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 97 (2000) 1566-1571
25. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., Shultz L.D., and Nishikawa S. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 (1990) 442-444
26. Okada Y., Montero A., Zhang X., Sobue T., Lorenzo J., Doetschman T., Coffin J.D., and Hurley M.M. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. J. Biol. Chem. 278 (2003) 21258-21266
27. Chikazu D., Hakeda Y., Ogata N., Nemoto K., Itabashi A., Takato T., Kumegawa M., Nakamura K., and Kawaguchi H. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J. Biol. Chem. 275 (2000) 31444-31450
28. Xu X., Qiao W., Li C., and Deng C.X. Generation of Fgfr1 conditional knockout mice. Genesis 32 (2002) 85-86
29. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., and Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8 (1999) 265-277
30. Jimi E., Shuto T., Ikebe T., Jingushi S., Hirata M., and Koga T. Basic fibroblast growth factor inhibits osteoclast-like cell formation. J. Cell. Physiol. 168 (1996) 395-402
31. Zuo J., Jiang J., Dolce C., and Holliday L.S. Effects of basic fibroblast growth factor on osteoclasts and osteoclast-like cells. Biochem. Biophys. Res. Commun. 318 (2004) 162-167
32. Nakagawa N., Yasuda H., Yano K., Mochizuki S., Kobayashi N., Fujimoto H., Shima N., Morinaga T., Chikazu D., Kawaguchi H., and Higashio K. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. Biochem. Biophys. Res. Commun. 265 (1999) 158-163
33. Chikazu D., Katagiri M., Ogasawara T., Ogata N., Shimoaka T., Takato T., Nakamura K., and Kawaguchi H. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. J. Bone Miner. Res. 16 (2001) 2074-2081
34. Kawaguchi H., Chikazu D., Nakamura K., Kumegawa M., and Hakeda Y. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures. J. Bone Miner. Res. 15 (2000) 466-473
35. Hurley M.M., Lee S.K., Raisz L.G., Bernecker P., and Lorenzo J. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22 (1998) 309-316
36. Collin-Osdoby P., Rothe L., Bekker S., Anderson F., Huang Y., and Osdoby P. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J. Bone Miner. Res. 17 (2002) 1859-1871
37. Kawaguchi H., Katagiri M., and Chikazu D. Osteoclastic bone resorption through receptor tyrosine kinase and extracellular signal-regulated kinase signaling in mature osteoclasts. Mod. Rheumatol. 14 (2004) 1-5
38. Shimoaka T., Ogasawara T., Yonamine A., Chikazu D., Kawano H., Nakamura K., Itoh N., and Kawaguchi H. Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J. Biol. Chem. 277 (2002) 7493-7500
39. Zhao Q., Shao J., Chen W., and Li Y.P. Osteoclast differentiation and gene regulation. Front. Biosci. 12 (2007) 2519-2529
40. Shinohara M., and Takayanagi H. Novel osteoclast signaling mechanisms. Curr. Osteoporos. Rep. 5 (2007) 67-72